| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | CFO and Secretary | COO, CFO, Treasurer & Secretary +1 more
2 companies
Or Eisenberg is Chief Financial Officer at NRSN, with reported holdings spanning 2 companies. Or Eisenberg's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.0M at current prices.
Or Eisenberg's largest disclosed position is in NRSN as Chief Financial Officer, worth about $1.9M. Net of sales, the NRSN filings show accumulation of 250,000 shares.
Or Eisenberg has 6 Form 4 filings on record from April 2018 to June 2026, across 2 companies: Chief Financial Officer at NeuroSense Therapeutics (NRSN), 2026; CFO and Secretary at Mawson Infrastructure Group (MIGI), 2018–2021.
The 7 reported transactions were 2 open-market purchases, 2 stock awards, 2 option or other derivative awards and 1 option exercise.
Counted by filing, the open-market trades come to 2 purchases worth about $300K and no sales.
The largest open-market purchase was 250,000 shares of NRSN at an average $0.80 on June 16, 2026, about $200K.